Cerebral ischemic tolerance induced by 3-nitropropionic acid is associated with increased expression of erythropoietin in rats

Abstract

To examine the changes in erythropoietin (Epo) protein and its mRNA expression in rat brain subjected to focal ischemia and possible mechanism of the preconditioning of mitochondrial toxin 3-nitropropionic acid (3-NPA), rats were administrated either vehicle or 3-NPA at a dose of 20 mg/kg, intraperitoneally (ip), 3 days prior to a 2-h middle cerebral artery occlusion followed by 24-h reperfusion. Infarct volumes were measured by using 2, 3, 5 triphenylte trazolinm chloride (TTC) staining, and Epo protein and its mRNA levels were assessed by immunohistochemistry and reverse transcriptase polymerase chain reaction (RT-PCR), respectively. Our results showed that after reperfusion, Epo was found to be expressed extensively in the rat brain. It was most apparent in the basal nuclei and hippocampus, and was, to some extent, present in cortex. Preconditioning with 3-NPA caused a reduction in infarct volume. The expression of both Epo protein and mRNA increased significantly in the different brain areas in the 3-NPA pretreated group as compared with the non-pretreated ischemia model group. These results suggested that preconditioning with low dose 3-NPA could induce ischemic tolerance and neuro-protective effects by increasing the Epo expression in the ischemic and ischemia-related areas.

Keywords

cerebral ischemia / 3-nitropropionic acid / immunohistochemistry / erythropoietin

References

[1] AbeH., NowakT. S.Jr, et al.. Gene expression and induced ischemic tolerance following brief insults. Acta Neurobiol Exp (Wars), 1996, 56: 3-8

[2] KuroiwaT., YamadaI., EndoS., et al.. 3-nitropropionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils. Neurosci Lett, 2000, 283: 145-148

[3] NakaseH., HeimannA., UranishiR., et al.. Early-onset tolerance in rat global cerebral ischemia induced by a mitochondrial inhibitor. Neurosci Lett, 2000, 290: 105-108

[4] SuginoT., NozakiK., TakagiY., et al.. 3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo. Neurosci Lett, 1999, 259: 9-12

[5] MartiH. H., BernaudinM., PetitE., et al.. Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. Physiol Sci, 2000, 15: 225-229

[6] BernaudinM., MartiH. H., RousselS., et al.. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab, 1999, 19: 643-651

[7] BrinesM. L., GhezziP., KeenanS., et al.. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA, 2000, 97: 10526-10531

[8] SakanakaM., WenT. C., MatsudaS., et al.. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA, 1998, 95: 4635-4640

[9] PrassK., ScharffA., RuscherK., et al.. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke, 2003, 34: 1981-1986

[10] RuscherK., FreyerD., KarschM., et al.. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci, 2002, 22: 10291-10301

[11] LongaE. Z., WeinsteinP. R., CarlsonS., et al.. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20: 84-91

[12] SwansonR. A., MortonM. T., Tsao-WuG., et al.. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab, 1990, 10: 290-293

[13] BrambrinkA. M., SchneiderA., NogaH., et al.. Tolerance-inducing dose of 3-nitropropi-onic acid modulates bcl-2 and Bax balance in the rat brain: a potential mechanism of chemical preconditioning. J Cereb Blood Flow Metab, 2000, 20: 1425-1436

[14] YaoH., TakasawaR., FukuduK., et al.. DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats. Mol Brain Res, 2001, 91: 112-118

[15] HoriguchiT., KisB., RajapakseN., et al.. Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke, 2001, 34: 1015-1020

[16] EhrenreichH., HasselblattM., DembowskiC., et al.. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med, 2002, 8: 495-505

[17] WiessnerC., AllegriniP. R., EkatodramisD., et al.. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab, 2001, 21: 857-864

[18] DawsonT. M., et al.. Preconditioning-mediated neuroprotection through erythropoietin?. Lancet, 2002, 359: 96-97

[19] von AmimC. A., TimmlerM., LudolphA. C., et al.. Adenosine receptor up-regulation: initiated upon preconditioning but not upheld. Neuroreport, 2000, 11: 1223-1226

[20] YaoZ., TongJ., TanX., et al.. Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol, 1999, 277: H2504-H2509